FDA 510(k)

BOND MMR抗体检测板

K号: K213348 · 2023-02-21

决定日期2023-02-21

产品代码PZJ

咨询委员会抱歉，您提供的信息不完整，无法进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

BOND MMR Antibody Panel is the device name listed in this FDA 510(k) record. The listed applicant is Leica Biosystems Newcastle, Ltd.. It received FDA 510(k) clearance on 2023-02-21 under 510(k) number K213348. The device is classified under product code PZJ. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the BOND MMR Antibody Panel?

BOND MMR Antibody Panel is a medical device that received FDA 510(k) clearance on 2023-02-21. The listed applicant is Leica Biosystems Newcastle, Ltd.. The 510(k) number is K213348.

When did BOND MMR Antibody Panel receive FDA 510(k) clearance?

BOND MMR Antibody Panel received FDA 510(k) clearance on 2023-02-21, under 510(k) number K213348.

Who is the listed applicant for BOND MMR Antibody Panel?

The FDA 510(k) record lists Leica Biosystems Newcastle, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BOND MMR Antibody Panel?

The FDA product code for BOND MMR Antibody Panel is PZJ.

列明Leica Biosystems Newcastle, Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K193393BOND即用型主要抗体孕酮受体（16），Novocastra液体小鼠单克隆抗体孕酮受体克隆16（浓缩液体抗体格式）

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。